Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
11/18/1999 | WO1999058691A2 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
11/18/1999 | WO1999058690A2 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch |
11/18/1999 | WO1999058687A2 Bacillus thuringiensis toxins and genes for controlling coleopteran pests |
11/18/1999 | WO1999058686A2 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b12 transport |
11/18/1999 | WO1999058684A2 Compounds from moraxella catarrhalis |
11/18/1999 | WO1999058683A2 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) |
11/18/1999 | WO1999058682A2 Compounds from moraxella catarrhalis |
11/18/1999 | WO1999058675A2 Human genes and gene expression products v |
11/18/1999 | WO1999058667A1 Rhotekin, a putative target for rho |
11/18/1999 | WO1999058660A1 97 human secreted proteins |
11/18/1999 | WO1999058643A1 Microorganism producing docosahexaenoic acid and phospholipase a1, liquid culture medium thereof, process for preparing phospholipid and process for producing 2-acyllysophospholipid |
11/18/1999 | WO1999058642A2 Secreted proteins and polynucleotides encoding them |
11/18/1999 | WO1999058563A2 Moraxella catharralis proteins |
11/18/1999 | WO1999058559A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
11/18/1999 | WO1999058558A2 Cell signaling proteins |
11/18/1999 | WO1999058546A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
11/18/1999 | WO1999058146A1 ATTENUATED MUTANTS OF SALMONELLA WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN |
11/18/1999 | WO1999058143A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
11/18/1999 | WO1999058137A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions |
11/18/1999 | WO1999057992A1 Compositions and methods for protein purification based on a metal ion affinity site |
11/18/1999 | WO1999050422A3 Method for reduction of fusel oils in alcoholic beverages and food products |
11/18/1999 | WO1999047673A3 Isolated mammalian membrane protein genes and related reagents |
11/18/1999 | WO1999047652A3 Novel rnase-like protein and its use |
11/18/1999 | WO1999047649A9 Polymerase chimeras |
11/18/1999 | WO1999046364A9 Vascular endothelial growth factor 2 |
11/18/1999 | WO1999046281A9 Novel polypeptides and nucleic acids encoding the same |
11/18/1999 | WO1999045124A3 Modified forms of pullulanase |
11/18/1999 | WO1999043830A3 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity |
11/18/1999 | WO1999038985A3 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI) |
11/18/1999 | WO1999038981A3 Human protein kinase molecules |
11/18/1999 | WO1999036550A3 Human protease molecules |
11/18/1999 | WO1999034003A3 Proteases from gram positive organisms |
11/18/1999 | WO1999028475A3 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
11/18/1999 | DE19826444C1 DNA encoding a spinach glucose translocator, plasmids, bacteria, yeast and transformed plant cells |
11/18/1999 | CA2332109A1 97 human secreted proteins |
11/18/1999 | CA2331311A1 Nucleic acid molecules encoding wheat enzymes involved in startch synthesis |
11/18/1999 | CA2331061A1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages |
11/18/1999 | CA2328589A1 Heteroduplex mutational vectors and use thereof in bacteria |
11/18/1999 | CA2328518A1 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
11/18/1999 | CA2328502A1 Cloning of basb020 antigen from moraxella catarrhalis |
11/18/1999 | CA2328477A1 Cell-free chimeraplasty and eukaryotic use of heteroduplex mutational vectors |
11/18/1999 | CA2328405A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
11/18/1999 | CA2328403A1 Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis |
11/18/1999 | CA2328141A1 Compounds from moraxella catarrhalis |
11/18/1999 | CA2328130A1 Moraxella catarrhalis proteins |
11/18/1999 | CA2328062A1 Secreted proteins and polynucleotides encoding them |
11/18/1999 | CA2327354A1 Human apoptosis associated proteins |
11/18/1999 | CA2327351A1 Cell signaling proteins |
11/18/1999 | CA2326722A1 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b12 transport |
11/18/1999 | CA2288993A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions |
11/17/1999 | EP0957173A1 Process for preparing fat or oil containing unsaturated fatty acid |
11/17/1999 | EP0957171A2 Recombinant microbial 3-hydroxybutyric acid dehydrogenase,process for their preparation and use |
11/17/1999 | EP0957170A1 Identification of Lactobacillus delbrueckii subsp bulgaricus Lfi5 genes involved in the biosynthesis of exopolysaccharides |
11/17/1999 | EP0957169A1 Identification of Lactobacillus helveticus LH59 genes involved in the biosynthesis of exopolysaccharides |
11/17/1999 | EP0957168A1 Identification of Streptococcus thermophilus Sfi39 genes involved in the biosynthesis of exopolysaccharides |
11/17/1999 | EP0957167A1 Production of heterodimeric human fertility hormones |
11/17/1999 | EP0956505A1 Motility channel pathogen detector and method of use |
11/17/1999 | EP0956357A1 Invertase inhibitor |
11/17/1999 | EP0956356A1 $i(CANDIDA UTILIS) TRANSFORMATION SYSTEM |
11/17/1999 | EP0956354A1 Recombinant n-proteinase, and the production, methods and uses thereof |
11/17/1999 | EP0956353A1 MANIPULATION OF CELLULOSE AND/OR $g(b)-1,4-GLUCAN |
11/17/1999 | EP0956351A1 A tumor necrosis factor related ligand |
11/17/1999 | EP0956350A1 Human chloride channel protein (hccp) |
11/17/1999 | EP0956348A1 A novel endoglucanase |
11/17/1999 | EP0956347A1 M. tuberculosis rna polymerase alpha subunit |
11/17/1999 | EP0956339A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
11/17/1999 | EP0956338A1 Novel host cells and methods of producing proteins |
11/17/1999 | EP0956337A1 Compositions and methods relating to the production, isolation, and modification of gas vesicles |
11/17/1999 | EP0956299A1 Peptide antagonists of dp transcription factors |
11/17/1999 | EP0956298A1 Snrnp sm proteins |
11/17/1999 | EP0956289A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
11/17/1999 | EP0956288A2 Novel polyketide derivatives and recombinant methods for making same |
11/17/1999 | EP0956042A2 Mycosis vaccines |
11/17/1999 | EP0956032A1 Proteins and compositions for modulating mitosis |
11/17/1999 | EP0955808A1 Human g-protein coupled receptor |
11/17/1999 | EP0955804A1 Expression of globin proteins in plants |
11/17/1999 | EP0604566B1 Chimeric and/or growth-restricted flaviviruses |
11/17/1999 | CN1235639A Reconstituted human anti-HM1.24 antibody |
11/17/1999 | CN1235638A Subtilase variants and compositions |
11/17/1999 | CN1235637A Subtilase variants and compositions |
11/17/1999 | CN1235636A Phospholipase, production and use thereof |
11/17/1999 | CN1235635A Extracellent expression of cellulose binding domains (CBD) using bacillus |
11/17/1999 | CN1235555A Compounds and methods for treatment and diagnosis of mycobacterial infections |
11/17/1999 | CN1235513A Nucleic acid and amino acid sequences ralating to helicobacter pylori and vaccine compositions thereof |
11/17/1999 | CN1235196A Manufacture of Sanzhen health-care products |
11/17/1999 | CN1235139A High effective biological organic fertilizer and preparation thereof |
11/17/1999 | CN1234980A Method for producing living cellular baits for young abalone from large kelp |
11/16/1999 | US5986069 Human haemopoietic maturation factor polypeptides |
11/16/1999 | US5986065 Antibodies for inhibiting blood coagulation and methods of use thereof |
11/16/1999 | US5986064 Antibodies which specifically bind to human tumor-associated Kazal inhibitor-like polypeptide |
11/16/1999 | US5986058 Growth differentiation factor with amino acid sequences |
11/16/1999 | US5986057 Amino acid sequences |
11/16/1999 | US5986055 CDK2 interactions |
11/16/1999 | US5986051 Genes of Helicobacter pylori necessary for the regulation and maturation of urease and their use |
11/16/1999 | US5986048 Process for obtaining insulin precursors having correctly bonded cystine bridges |
11/16/1999 | US5985831 Methods for controlling lepidopterans using Bacillus thuringiensis toxins obtainable from isolates PS17, PS86Q3, and HD511 |
11/16/1999 | US5985668 A dna sequence coding for a protein with a sucrose isomerase activity wherein sucrose is isomerized to palatinose and/or trehalose wherein the cell displays a reduced sucrose metabolism; genetic engineering |
11/16/1999 | US5985665 Biochemical analysis of antioxidant function of lymphocytes in culture |
11/16/1999 | US5985657 Nucleotide sequence coding for human il-1; expression vectors and host cells |
11/16/1999 | US5985650 Enhancing the rate of desulfurization of fossil fuels by the addition of a flavoprotein to the biocatalyst; contacting the fossil fuel with an aqueous phase containing the biocatalyst and flavoprotein, later separating reduced sulfur fuel |